Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$0.041
▾0.001 (2.38%)
Last trade: 20/12, 10:23PM
Market cap
$33.02m
Market closed
Talk to Prescient Therapeutics Limited directly.
Sign up to their Investor Hub for direct access to the Prescient Therapeutics Limited team, ask them questions, and see personal updates.
Investor Presentations
Principal Activity
Prescient Therapeutics is a clinical stage oncology company developing novel drugs that show great promise as potential new therapies to treat a range of cancers that have become resistant to front line chemotherapy.
Address
Level 4/100 Albert Rd, South Melbourne VIC 3205, Australia
Website
News
Announcements
Filter
| Announcement | T+2 Movement | Date |
|---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$0.041
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
| Company | Market Cap | ||
|---|---|---|---|
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.
Support
Live Chat
Markets
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.